Actively Recruiting
Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy - IGROWtoh
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2026-03-03
2000
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observational research project conducted across multiple centers in Italy to understand and describe changes over time in the use of techniques for inducing liver growth (hepatic hypertrophy). It focuses on patients with liver tumors or cancer who require liver surgery but have a future liver remnant volume considered too small by their medical teams. The goal is to compare and understand different methods used over recent years to help guide treatment decisions. Participants are observed according to the usual care practices at their treatment centers. The study includes two groups: a prospective group followed from recruitment and observed for up to five years after liver surgery to record health events, and a retrospective group made up of patients treated with these hypertrophy techniques in the past ten years. This historical data will be used to compare with the new patient group to better understand trends and outcomes. Throughout the study, information about patients' health status, including survival and disease progression, will be collected regularly. Researchers will track various outcomes such as liver function, growth in liver volume, dropout rates from treatment, short-term mortality within 90 days, long-term survival, and disease-free survival. This comprehensive follow-up helps to evaluate the effectiveness and safety of the different hypertrophy techniques used in clinical practice in Italy.
CONDITIONS
Brief Title
Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 or older
- Provided informed consent
- Diagnosed with liver neoplasia (benign or malignant)
- Future liver remnant volume considered insufficient (less than 20%-40%) by local multidisciplinary team
You will not qualify if you...
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants who underwent hepatic hypertrophy techniques are observed to record clinical events, outcomes, and survival for up to 5 years after surgery.
Periodic visits as determined by treating centers
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitario di Bologna
Bologna, Bologna, Italy, 401328
Actively Recruiting
Research Team
E
Elio Jovine, MD
M
Matteo Serenari, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here